Cargando…

Stem Cell and Exosome Therapy in Pulmonary Hypertension

Pulmonary hypertension is a rare and progressive illness with a devastating prognosis. Promising research efforts have advanced the understanding and recognition of the pathobiology of pulmonary hypertension. Despite remarkable achievements in terms of improving the survival rate, reducing disease p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Seyeon, Jung, Ji-Hye, Ahn, Kyung-Jin, Jang, Albert Youngwoo, Byun, Kyunghee, Yang, Phillip C., Chung, Wook-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2022
Materias:	State of the Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819574/ https://www.ncbi.nlm.nih.gov/pubmed/35128849 http://dx.doi.org/10.4070/kcj.2021.0191

Ejemplares similares

A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort
por: Jang, Albert Youngwoo, et al.
Publicado: (2019)

Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
por: Oh, Seyeon, et al.
Publicado: (2021)

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019)

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review
por: Wesley Milks, Michael, et al.
Publicado: (2021)

Pulmonary Hypertension in Heart Failure
por: Jang, Albert Youngwoo, et al.
Publicado: (2021)

Current status of pulmonary arterial hypertension in Korea
por: Jang, Albert Youngwoo, et al.
Publicado: (2019)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Pulmonary Hypertension Caused by Fibrosing Mediastinitis
por: Wang, Aqian, et al.
Publicado: (2022)

Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia
por: Anderson, James J., et al.
Publicado: (2022)

Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
por: Kandzari, David E., et al.
Publicado: (2022)

Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
por: Prisco, Sasha Z., et al.
Publicado: (2020)

Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges
por: Santos-Ferreira, Cátia A., et al.
Publicado: (2020)

Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
por: Calvier, Laurent, et al.
Publicado: (2022)

Anomalous aortic origin of the pulmonary arteries: Case series and literature review
por: Agati, Salvatore, et al.
Publicado: (2019)

Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies
por: Fernandes, Susan, et al.
Publicado: (2021)

Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
por: Nannya, Yasuhito, et al.
Publicado: (2022)

Standardization and Accreditation in Haemopoietic Stem Cell Transplantation - an Asia Pacific Perspective
por: Damodar, Sharat, et al.
Publicado: (2021)

Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting Factors
por: Zhu, Jinsheng, et al.
Publicado: (2022)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

No small matter: emerging roles for exosomal miRNAs in the immune system
por: Bauer, Kaylyn M., et al.
Publicado: (2021)

Implementation of National Health Policy for the Prevention and Control of Cardiovascular Disease in South Korea: Regional-Local Cardio-Cerebrovascular Center and Nationwide Registry
por: Wang, Ju Mee, et al.
Publicado: (2021)

Strategy of Patient-Specific Therapeutics in Cardiovascular Disease Through Single-Cell RNA Sequencing
por: Jung, Yunseo, et al.
Publicado: (2022)

Personal strategies to minimise effects of air pollution on respiratory health: advice for providers, patients and the public
por: Carlsten, Christopher, et al.
Publicado: (2020)

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
por: Youssef, Amr A., et al.
Publicado: (2016)

Attenuating Effects of Dieckol on Hypertensive Nephropathy in Spontaneously Hypertensive Rats
por: Son, Myeongjoo, et al.
Publicado: (2021)

A long journey for acute kidney injury biomarkers
por: Oh, Dong-Jin
Publicado: (2020)

Exercise-Induced Cardiac Troponin Elevations: From Underlying Mechanisms to Clinical Relevance
por: Aengevaeren, Vincent L., et al.
Publicado: (2021)

Managing Hypertension in the elderly: What’s new?
por: Aronow, Wilbert S.
Publicado: (2020)

Management of hypertension in obstructive sleep apnea
por: Ou, Yi-Hui, et al.
Publicado: (2023)

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction
por: Chang, Kiyuk, et al.
Publicado: (2021)

Interventions for Adherence Improvement in the Primary Prevention of Cardiovascular Diseases: Expert Consensus Statement
por: Ihm, Sang Hyun, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy in Infants from the Perspective of Cardiomyocyte Maturation
por: Seok, Heeyoung, et al.
Publicado: (2021)

Hyponatremia in patients with arterial hypertension: pathophysiology and management
por: Adamczak, Marcin, et al.
Publicado: (2023)

Historical Review and Future of Cardiac Xenotransplantation
por: Koh, Jiwon, et al.
Publicado: (2023)

Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management
por: Cohen, Jordana B., et al.
Publicado: (2019)

The Use of Machine Learning for the Care of Hypertension and Heart Failure
por: Cai, Anping, et al.
Publicado: (2021)

Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS)
por: Kim, Hack-Lyoung, et al.
Publicado: (2021)

Clinical update on pulmonary embolism
por: Duru, Serap, et al.
Publicado: (2013)

Pulmonary Complications of Cardiac Surgery
por: Tanner, Tristan George, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gqb6echogqka73v9hkm6cvd47b